OTS167
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OTS167, covering 2017-06-01 to 2017-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of OTS167 in Patients With Solid Tumors [Phase 1]